GSK To Build Green Drug Research, Production Center In Brazil
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline plans to establish an environmental-friendly drug research-and-production center in Brazil at a $647,000-a-year cost over the next 10 years, in partnership with the Sao Paulo Research Foundation.